RESMED INC — Director's Dealing 2014

Sep 4, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2014-09-02

Reporting Person: Douglas Robert Andrew (President and COO ResMed Inc.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-09-02	ResMed Common Stock	M	7500	$15.52	Acquired	46630.17	Indirect
2014-09-02	ResMed Common Stock	S	7500	$52.997	Disposed	39130.17	Indirect
2014-09-02	ResMed Common Stock	S	500	$53.00	Disposed	38630.17	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-09-02	ResMed Common Stock Options	$15.52	M	7500	Disposed	2015-11-20	ResMed Common Stock (7500)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	86750.44	Direct

Footnotes

F1: The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.

F2: Represents date options first became exercisable. Options vest 1/4 per year on the anniversary of the grant.

F3: This transaction was executed in multiple trades at prices ranging from $52.82 to $53.40. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.